FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1341646 · Received March 9, 2009

Report

Report Number
2024168-2009-00390
Event Type
Injury
Date Received
March 9, 2009
Date of Event
November 26, 2008
Report Date
February 12, 2009
Manufacturer
ABBOTT VASCULAR-CARDIAC THERAPIES
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

RESULTS AND CONCLUSION SUMMATION - DISSECTION IS A KNOWN POSSIBLE OUTCOME OF CORONARY STENTING PROCEDURES, AND LISTED IN THE IFU, AS A POTENTIAL ADVERSE EVENT. HOWEVER, IT WAS NOTED THAT NO PRE-DILATATION WAS PERFORMED PRIOR TO STENTING THE LESION. THE IFU STATES: "THE VESSEL SHOULD BE PRE-DILATED WITH AN APPROPRIATE SIZED BALLOON. FAILURE TO DO SO MAY INCREASE THE DIFFICULTY OF STENT PLACEMENT AND CAUSE PROCEDURAL COMPLICATIONS." ALTHOUGH A CAUSE FOR THE DISSECTION AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE ARE NO INDICATIONS OF A DEVICE DEFICIENCY WHICH COULD HAVE CONTRIBUTED TO THE OUTCOME OF THE PROCEDURE.

Description of Event or Problem · 1

REPORTING STATUS: SERIOUS INJURY/MEDICAL INTERVENTION. REPORTING RATIONALE: DISSECTION, REQUIRING MEDICAL INTERVENTION TO PREVENT PERMANENT IMPAIRMENT OR DAMAGE. DEVICE ISSUE: NO DEVICE MALFUNCTION HAS BEEN REPORTED. IT WAS REPORTED VIA A TRAIL THAT DURING THE PROCEDURE IN 2008, A 3.0 X 23 MM XIENCE V STENT WAS DEPLOYED IN THE MID LAD, WITHOUT PRE-DILATATION. AFTER THE STENT WAS DEPLOYED, A DISSECTION WAS NOTED AND AN ADDITIONAL 3.0 X 08 MM XIENCE V STENT WAS DEPLOYED TO COVER THE DISSECTION. NO ADDITIONAL EVENT OR PT INFO IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM NIQ ABBOTT VASCULAR-CARDIAC THERAPIES NA 8072461

Patients

Seq Age Sex Outcome Treatment
1 65 YR Required Intervention